Welcome to LookChem.com Sign In|Join Free
  • or
(3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-carbamic acid tert-butyl ester, 98+% C15H22N4O4, MW: 322.36 is a complex organic compound with a molecular formula of C15H22N4O4 and a molecular weight of 322.36. It is a tert-butyl ester derivative of a carboxylic acid, featuring a nitro group and a bipyridinyl ring structure. This chemical is utilized in organic synthesis and research, with a purity of 98% or higher. It may have potential applications in medicinal chemistry, material science, or as a building block for the preparation of other organic compounds.

939986-23-9

Post Buying Request

939986-23-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

939986-23-9 Usage

Uses

Used in Organic Synthesis:
(3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-carbamic acid tert-butyl ester, 98+% C15H22N4O4, MW: 322.36 is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure allows for further functionalization and modification, making it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-carbamic acid tert-butyl ester, 98+% C15H22N4O4, MW: 322.36 is used as a building block for the development of new drugs. Its bipyridinyl ring and nitro group can be exploited to create novel molecular entities with potential therapeutic properties, such as antimicrobial, anticancer, or antiviral agents.
Used in Material Science:
(3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-carbamic acid tert-butyl ester, 98+% C15H22N4O4, MW: 322.36 may also find applications in material science, where its unique chemical structure can be employed to develop new materials with specific properties. These could include advanced polymers, coatings, or other materials with tailored characteristics for use in various industries.
Used in Research:
In research settings, (3'-Nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-3-yl)-carbamic acid tert-butyl ester, 98+% C15H22N4O4, MW: 322.36 serves as a valuable compound for studying the properties and reactivity of complex organic molecules. It can be used to investigate reaction mechanisms, explore new synthetic routes, and develop innovative methodologies in organic chemistry.

Check Digit Verification of cas no

The CAS Registry Mumber 939986-23-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,9,8 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 939986-23:
(8*9)+(7*3)+(6*9)+(5*9)+(4*8)+(3*6)+(2*2)+(1*3)=249
249 % 10 = 9
So 939986-23-9 is a valid CAS Registry Number.

939986-23-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl [1-(3-nitro-2-pyridinyl)-3-piperidinyl]carbam ate

1.2 Other means of identification

Product number -
Other names tert-butyl 1-(3-nitropyridin-2-yl)piperidin-3-ylcarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:939986-23-9 SDS

939986-23-9Upstream product

939986-23-9Downstream Products

939986-23-9Relevant academic research and scientific papers

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

-

Page/Page column 47, (2008/12/07)

New compounds, compositions and methods of inhibition of kinase activity associated with tumorigenesis in a human or animal subject are provided. In certain embodiments, the compounds and compositions are effective to inhibit the activity of at least one serine/threonine kinase or receptor tyrosine kinase. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a serine/threonine kinase- or receptor tyrosine kinase- mediated disorder, such as cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 939986-23-9